The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review.
Allergy
Anaphylaxis
Angioedema
Antihistamine
Cetirizine
Chemotherapy
Diphenhydramine
Infusion
Intravenous
Urticaria
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
18
10
2021
accepted:
15
11
2021
pubmed:
5
12
2021
medline:
9
3
2022
entrez:
4
12
2021
Statut:
ppublish
Résumé
Since 1955, the only available H
Identifiants
pubmed: 34862952
doi: 10.1007/s12325-021-01999-x
pii: 10.1007/s12325-021-01999-x
pmc: PMC8643118
doi:
Substances chimiques
Histamine H1 Antagonists
0
Diphenhydramine
8GTS82S83M
Cetirizine
YO7261ME24
Types de publication
Journal Article
Review
Langues
eng
Pagination
178-192Informations de copyright
© 2021. The Author(s).
Références
Akdis C, Jutel M, Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem Immunol Allergy. 2008;94:67–82.
doi: 10.1159/000154858
Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003;112(1):15–22.
doi: 10.1067/mai.2003.1585
Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139-50.e4.
doi: 10.1016/j.jaci.2011.09.005
Bernstein J, Leslie T. Antihistamines. In: Grammer LC, Greenberger PA, editors. Patterson’s allergic diseases. 8th ed. Philadelphia: Wolters Kluwer Health; 2018. p. 719–34.
Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–7.
doi: 10.1016/j.jaci.2014.02.036
Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4):721–67.
doi: 10.1016/j.jaci.2020.07.007
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA
Church MK, Maurer M, Simons FER, et al. Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy. 2010;65(4):459–66.
doi: 10.1111/j.1398-9995.2009.02325.x
Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361:k1315.
doi: 10.1136/bmj.k1315
Vistaril® (hydroxyzine pamoate) capsules and oral suspension. New York, NY: Pfizer Labs; 2014.
Diphenhydramine hydrochloride injection. Lake Forest, IL: Hospira, Inc.; 2019.
Quzyttir™ (cetirizine hydrochloride injection). Deerfield, IL: TerSera Therapeutics LLC; 2020.
Berlinger WG, Goldberg MJ, Spector R, Chiang CK, Ghoneim M. Diphenhydramine: kinetics and psychomotor effects in elderly women. Clin Pharmacol Ther. 1982;32(3):387–91.
doi: 10.1038/clpt.1982.176
Blyden GT, Greenblatt DJ, Scavone JM, Shader RI. Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration. J Clin Pharmacol. 1986;26(7):529–33.
doi: 10.1002/j.1552-4604.1986.tb02946.x
Simons KJ, Watson WT, Martin TJ, Chen XY, Simons FE. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol. 1990;30(7):665–71.
doi: 10.1002/j.1552-4604.1990.tb01871.x
Krystal AD, Richelson E, Roth T. Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications. Sleep Med Rev. 2013;17(4):263–72.
doi: 10.1016/j.smrv.2012.08.001
Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG. Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes. Bioorg Med Chem. 2006;14(19):6640–58.
doi: 10.1016/j.bmc.2006.05.077
Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P. Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol. 2002;61(2):391–9.
doi: 10.1124/mol.61.2.391
Data on File. ETTAU-02 Clinical study report. TerSera Therapeutics; 2015.
Abella BS, Berger WE, Blaiss MS, et al. Intravenous cetirizine versus intravenous diphenhydramine for the treatment of acute urticaria: a phase III randomized controlled noninferiority trial. Ann Emerg Med. 2020;76(4):489–500.
doi: 10.1016/j.annemergmed.2020.05.025
Zilberberg MD, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc. 2010;31(6):511–9.
doi: 10.2500/aap.2010.31.3403
Pall AH, Lomholt AF, von Buchwald C, Bygum A, Rasmussen ER. Clinical features and disease course of primary angioedema patients in a tertiary care hospital. J Asthma Allergy. 2020;13:225–36.
doi: 10.2147/JAA.S245161
Moellman JJ, Bernstein JA, Lindsell C, et al. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014;21(4):469–84.
doi: 10.1111/acem.12341
James C, Bernstein JA. Current and future therapies for the treatment of histamine-induced angioedema. Expert Opin Pharmacother. 2017;18(3):253–62.
doi: 10.1080/14656566.2017.1282461
Long BJ, Koyfman A, Gottlieb M. Evaluation and management of angioedema in the emergency department. West J Emerg Med. 2019;20(4):587–600.
doi: 10.5811/westjem.2019.5.42650
Baram M, Kommuri A, Sellers SA, Cohn JR. ACE inhibitor-induced angioedema. J Allergy Clin Immunol Pract. 2013;1(5):442–5.
doi: 10.1016/j.jaip.2013.07.005
Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021;9(1):132-50 e3.
doi: 10.1016/j.jaip.2020.08.046
Data on file. ETTAU-03. https://clinicaltrials.gov/ct2/show/NCT02023164 . TerSera Therapeutics; 2020.
Roselló S, Blasco I, García Fabregat L, Cervantes A, Jordan K. Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2017;28(suppl_4):iv100–18.
doi: 10.1093/annonc/mdx216
Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–73.
Ovarian cancer including fallopian tube cancer and primary peritoneal cancer: NCCN Clinical Practice Guidelines in Oncology. Version 2.2020. National Comprehensive Cancer Network. 2021. https://www.nccn.org/professionals/physician_gls/default.aspx#site . Accessed 15 Oct 2021.
Taxol (paclitaxel) injection. Princeton, NJ: Bristol-Myers Squibb Company; 2011.
Adcetris™ (brentuximab vedotin) for injection. Bothell, WA: Seattle Genetics, Inc.; 2012.
Erbitux® (cetuximab) injection, for intravenous use. Indianapolis, IN: Eli Lilly and Company; 2020.
Darzalex (daratumumab) injection, for intravenous use. Horsham, PA: Janssen Biotech, Inc.; 2020.
Arzerra® (ofatumumab) injection, for intravenous use. East Hanover, NJ: Novartis Pharmaceutical Corporation; 2016.
Rituxan® (rituximab) injection, for intravenous use. South San Franciso, CA: Genentech, Inc.; 2018.
Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol. 2009;102(3):179–87.
doi: 10.1016/S1081-1206(10)60078-6
ten Bokkel Huinink WW, Eisenhauer E, Swenerton K, Canadian-European Taxol Cooperative Trial Group. Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Cancer Treat Rev. 1993;19(Suppl C):79–86.
doi: 10.1016/0305-7372(93)90050-2
Kintzel PE. Prophylaxis for paclitaxel hypersensitivity reactions. Ann Pharmacother. 2001;35(9):1114–7.
doi: 10.1345/aph.10287
Holmes JP, Peguero J, Campbell Garland R, et al. Intravenous cetirizine vs intravenous diphenhydramine for the prevenstion of hypersensitivity infusion reactions: results of an exploratory phase 2 study. J Infus Nurs. 2021. https://doi.org/10.1097/NAN.0000000000000444 .
doi: 10.1097/NAN.0000000000000444
pubmed: 34555839
pmcid: 8565502
Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175(3):621–8.
doi: 10.1148/radiology.175.3.2343107
Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA. Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children’s hospital–retrospective analysis of data in 12,494 patients. Radiology. 2009;250(3):674–81.
doi: 10.1148/radiol.2503071577
Salem DN, Findlay SR, Isner JM, Konstam MA, Cohen PF. Comparison of histamine release effects of ionic and non-ionic radiographic contrast media. Am J Med. 1986;80(3):382–4.
doi: 10.1016/0002-9343(86)90710-2
ACR manual on contrast media. American College of Radiology. 2021. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf . Accessed 15 Oct 2021.
Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472.
doi: 10.1016/j.waojou.2020.100472
Tomasiak-Lozowska MM, Klimek M, Lis A, Moniuszko M, Bodzenta-Lukaszyk A. Markers of anaphylaxis—a systematic review. Adv Med Sci. 2018;63(2):265–77.
doi: 10.1016/j.advms.2017.12.003
Fineman SM. Optimal treatment of anaphylaxis: antihistamines versus epinephrine. Postgrad Med. 2014;126(4):73–81.
doi: 10.3810/pgm.2014.07.2785
Campbell RL, Li JT, Nicklas RA, et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599–608.
doi: 10.1016/j.anai.2014.10.007
Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082–123.
doi: 10.1016/j.jaci.2020.01.017
CDC. General best practice guidelines for immunization: Best practices guidance of the Advisory Committee on Immunization Practices. Preventing and managing adverse reactions. Centers for Disease Control and Prevention, Atlanta, GA. 2020. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/adverse-reactions.pdf . Accessed 15 Oct 2021.
CDC. Interim considerations: Preparing for the potential management of anaphylaxis after COVID-19 vaccination. Centers for Disease Control and Prevention, Atlanta, GA. 2021. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/managing-anaphylaxis.html . Accessed 15 Oct 2021.
vanSonnenberg E, Neff CC, Pfister RC. Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy. Radiology. 1987;162(1 Pt 1):15–9.
doi: 10.1148/radiology.162.1.3786753
Brown AF. Therapeutic controversies in the management of acute anaphylaxis. J Accid Emerg Med. 1998;15(2):89–95.
doi: 10.1136/emj.15.2.89
Moskowitz H, Jeavons Wilkinson C. Antihistamines and driving-related behavior: a review of the evidence for impairment. Report DOT HS 809 714. US Department of Transportation. 2004. https://one.nhtsa.gov/people/injury/research/antihistamines/Antihistamines%20Web/pages/1%20Introduction.htm . Accessed 15 Oct 2021.
Gilmore TM, Alexander BH, Mueller BA, Rivara FP. Occupational injuries and medication use. Am J Ind Med. 1996;30(2):234–9.
doi: 10.1002/(SICI)1097-0274(199608)30:2<234::AID-AJIM16>3.0.CO;2-Y
Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132(5):354–63.
doi: 10.7326/0003-4819-132-5-200003070-00004
Sharma A, Hamelin BA. Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a birds eye view. Curr Drug Metab. 2003;4(2):105–29.
doi: 10.2174/1389200033489523
Hamelin BA, Bouayad A, Méthot J, et al. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther. 2000;67(5):466–77.
doi: 10.1067/mcp.2000.106464
Baker DE. Cetirizine hydrochloride injection. Hosp Pharm. 2020. https://doi.org/10.1177/0018578720910386 .
doi: 10.1177/0018578720910386
2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4): 674–94.
Bloudek LM, Ho LK, Kapur N, Brent LD. Budget impact of intravenous cetirizine hydrochloride for the treatment of acute urticaria in the United States emergency department setting. American Society of Health-System Pharmacists midyear clinical meeting; 2020; Virtual meeting.